HWH International together with Alset Capital Acquisition Corp. Announce Closing of Business Combination
January 08, 2024 12:20 ET
|
Alset Capital Acquisition Corp.
The common stock of the combined company is expected to commence trading on The Nasdaq Global Market under ticker symbol “HWH” on January 9, 2024. Bethesda, MD, Jan. 08, 2024 (GLOBE NEWSWIRE) --...
First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024
January 04, 2024 06:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.
December 27, 2023 08:01 ET
|
PowerUp Acquisition Corp.
Tarrytown, NY and New York, NY, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Visiox Pharmaceuticals, Inc. (“Visiox” or the “Company”), a commercial-stage biopharmaceutical company, and PowerUp Acquisition...
Alternus Energy Group Plc Completes Business Combination with Clean Earth Acquisitions Corp.
December 22, 2023 16:50 ET
|
Alternus Clean Energy
• Alternus Energy Group becomes majority shareholder in Alternus Clean Energy Inc.• Commences trading on NASDAQ under the ticker “ALCE” DUBLIN, Ireland, Dec. 22, 2023 (GLOBE NEWSWIRE) --...
Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
December 20, 2023 16:15 ET
|
Kairous Acquisition Corp. Limited
Singapore, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Kairous Acquisition Corp. Limited (NASDAQ: KACL, the “Company”), a special purpose acquisition company, announced today that Kairous Asia Limited, the...
First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company
December 18, 2023 06:00 ET
|
First Wave BioPharma, Inc.
Phase 3-ready latiglutenase, a targeted oral biotherapeutic for celiac disease, will expand First Wave BioPharma’s late-stage gastrointestinal (GI) disease clinical pipeline A concurrent...
Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination
December 12, 2023 08:35 ET
|
Digital Ally, Inc.
KANSAS CITY, KS and MIAMI, FL, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (“Digital Ally”) and Clover Leaf Capital Corp. (Nasdaq: CLOE) (“CLOE”), a publicly traded special...
Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to December 9, 2023
December 07, 2023 16:15 ET
|
Globalink Investment Inc.
New York, NY, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (Nasdaq: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today...
Globalink Investment Inc. Announces Charter and Trust Agreement Amendments
December 04, 2023 16:15 ET
|
Globalink Investment Inc.
New York, NY, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (Nasdaq: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink” or the “Company”), a special purpose acquisition company, announced today...
Kairous Acquisition Corp. Limited Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
November 13, 2023 08:30 ET
|
Kairous Acquisition Corp. Limited
Malaysia, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Kairous Acquisition Corp. Limited (NASDAQ: KACL, the “Company”), a special purpose acquisition company, announced today that Kairous Asia Limited, the...